Brott D A, Alvey J D, Bleavins M R, de la Iglesia F A, Lalwani N D
Department of Pathology and Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48106.
J Cell Biochem. 1993 Jul;52(3):362-72. doi: 10.1002/jcb.240520312.
The aim of the present study was to investigate bromodeoxyuridine (BrdU) uptake and coordinated distribution of proliferating cell nuclear antigen (PCNA) and p34-cdc2-kinase, two important proteins involved in cell cycle regulation and progression. Flow cytometric analysis of marker proteins in freshly plated mouse T-lymphoma cells (Yac-1 cells), using fluorescein isothiocyanate (FITC)-labeled specific antibodies, showed PCNA distributed throughout the cell cycle with increased intensity in S-phase. PCNA is essential for cells to cycle through S-phase and its synthesis is initiated during late G1-phase before incorporation of BrdU and remains high during active DNA replication. The intensity of PCNA fluorescence increases with the duration of incubation after plating. The cdc2-kinase was detectable in all phases of the cell cycle and the G2-M-phase appears to have the maximum concentrations. The cell cycle analysis of high dose colcemid (2 micrograms/ml) treated Yac-1 cells showed an aneuploid or hypodiploid population. Although the G2-M-phase seems to be the dominating population in aneuploid cells, the concentrations of cdc2-kinase were variable in this phase of cell cycle. The colcemid treatment at 25 ng/ml arrested 96% of cells in S-phase and G2-M-phase, but PCNA expression was evident in a portion of the cell population in G2-M-phase. Although cells blocked in M-phase seem to have high levels of cdc2-kinase, colcemid renders them inactive. From these data, it appears that the down regulation and/or inactivation of cdc2-kinase could be responsible for the colcemid arrest of cells in M-phase.
本研究的目的是调查溴脱氧尿苷(BrdU)的摄取以及增殖细胞核抗原(PCNA)和p34-cdc2激酶的协同分布,这两种重要蛋白质参与细胞周期调控和进程。使用异硫氰酸荧光素(FITC)标记的特异性抗体,对新鲜接种的小鼠T淋巴瘤细胞(Yac-1细胞)中的标记蛋白进行流式细胞术分析,结果显示PCNA在整个细胞周期中均有分布,在S期强度增加。PCNA对于细胞通过S期循环至关重要,其合成在G1期晚期开始,先于BrdU掺入,并且在活跃的DNA复制期间保持高水平。接种后,PCNA荧光强度随孵育时间延长而增加。在细胞周期的所有阶段均能检测到cdc2激酶,G2-M期的浓度似乎最高。高剂量秋水仙酰胺(2微克/毫升)处理的Yac-1细胞的细胞周期分析显示为非整倍体或亚二倍体群体。尽管在非整倍体细胞中G2-M期似乎是主要群体,但在细胞周期的这个阶段cdc2激酶的浓度是可变的。25纳克/毫升的秋水仙酰胺处理使96%的细胞停滞在S期和G2-M期,但在G2-M期的一部分细胞群体中PCNA表达明显。尽管停滞在M期的细胞似乎具有高水平的cdc2激酶,但秋水仙酰胺使其失活。从这些数据来看,cdc2激酶的下调和/或失活可能是秋水仙酰胺使细胞停滞在M期的原因。